Baker Bros. Advisors’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-9,523
| Closed | -$643K | – | 104 |
|
|
2023
Q2 | $643K | Sell |
9,523
-95,972
| -91% | -$6.48M | ﹤0.01% | 101 |
|
|
2023
Q1 | $49.2M | Buy |
105,495
+50,487
| +92% | +$23.6M | 0.27% | 22 |
|
|
2022
Q4 | $22M | Buy |
55,008
+22,379
| +69% | +$8.96M | 0.13% | 39 |
|
|
2022
Q3 | $10.6M | Hold |
32,629
| – | – | 0.07% | 61 |
|
|
2022
Q2 | $8.61M | Buy |
32,629
+9,359
| +40% | +$2.47M | 0.05% | 67 |
|
|
2022
Q1 | $6.99M | Buy |
23,270
+64
| +0.3% | +$19.2K | 0.04% | 77 |
|
|
2021
Q4 | $8.18M | Buy |
+23,206
| New | +$8.18M | 0.04% | 82 |
|